LRCX
37
-9
EBAY
42
-2
FOX
51
-6
NAVI
52
-2
EL
15
-3
AVGO
18
-9
WYNN
36
-5
IPG
34
-9
TDC
67
-4
AMGN
42
-4
TSCO
44
-4
FOXA
52
-14
BMY
55
-8
MLM
45
-5
EQR
54
3
INTC
41
4
BSX
64
-3
FITB
60
-5
SWKS
38
-2
PG
50
2
LRCX
37
-9
EBAY
42
-2
FOX
51
-6
NAVI
52
-2
EL
15
-3
AVGO
18
-9
WYNN
36
-5
IPG
34
-9
TDC
67
-4
AMGN
42
-4
TSCO
44
-4
FOXA
52
-14
BMY
55
-8
MLM
45
-5
EQR
54
3
INTC
41
4
BSX
64
-3
FITB
60
-5
SWKS
38
-2
PG
50
2
Financhill
Back

Akamai Technologies Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
43

AKAM
Akamai Technologies

Last Price:
87.45
Seasonality Move:
9.02%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
43
Akamai Technologies (AKAM) is a Sell

Is Akamai Technologies a Buy, Sell or Hold?

  • The current Akamai Technologies [AKAM] share price is $87.43. The Score for AKAM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • AKAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKAM Stock Price Chart

What is Akamai Technologies's stock price today?

  • The Akamai Technologies share price today is $87.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKAM is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AKAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.45 Sell
Relative Strength Index (14 RSI): 27.11 Sell
Chaikin Money Flow: -1391959 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.6 - 106) Sell
Bollinger Bands (100): (93.49 - 102.77) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AKAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.03 Sell
20-day SMA: 98.68 Sell
50-day SMA: 99.68 Sell
200-day SMA: 100.78 Sell
8-day EMA: 91.84 Sell
20-day EMA: 96.4 Sell
50-day EMA: 98.67 Sell
200-day EMA: 100.03 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Akamai Technologies Earnings Growth & AKAM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.39 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Akamai Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):